Development of an itraconazole encapsulated polymeric nanoparticle platform for effective antifungal therapy
| Autor: | Farhana Abbas, Jiarong Xie, Feng Min, Xiang Ling, Jianzhao Wang, Zewei Huang, Chunmeng Sun, Yang Chen, Jiasheng Tu, Jun Wu |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Biodistribution
Materials science Biocompatibility Itraconazole Biomedical Engineering 02 engineering and technology Pharmacology 010402 general chemistry 01 natural sciences chemistry.chemical_compound medicine Zeta potential General Materials Science chemistry.chemical_classification Cyclodextrin technology industry and agriculture General Chemistry General Medicine 021001 nanoscience & nanotechnology 0104 chemical sciences Lactic acid chemistry 0210 nano-technology Drug carrier Ethylene glycol medicine.drug Nuclear chemistry |
| Zdroj: | Journal of Materials Chemistry B. 4:1787-1796 |
| ISSN: | 2050-7518 2050-750X |
| Popis: | This study is to develop a novel itraconazole-loaded nanoparticle (ITZ-NP) platform for effective antifungal therapy. First, the monomethoxypoly(ethylene glycol)-b-poly(lactic acid) (mPEG-b-PLA) copolymer was prepared as a drug carrier material. Then the nanoparticles were formulated via a simple film hydration method. The copolymer and nanoparticles were characterized by standard methods, including 1H NMR, 13C NMR, FT-NIR, DSC, XRPD, and particle size, zeta potential, morphology and physical examination. Furthermore, in vitro itraconazole release and antifungal activity were intensively evaluated. The results showed that the formed nanoparticles significantly enhanced sustained drug release and inhibited fungal infection. In addition, ITZ-NPs caused very mild hemolysis and slight venous irritation, indicating much better biocompatibility than marketed cyclodextrin formulations of ITZ. An Iin vivo biodistribution study via intravenous injection showed that ITZ-NPs could be effectively retained in blood circulation and selectively distributed in RES-rich organs compared with commercial cyclodextrin injection, with the verification of Re, Te, RTe and Ce. In summary, the developed ITZ-NPs could reduce systemic toxicity, improve antifungal activity and act as a potential intravenous formulation of ITZ. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|